دورية أكاديمية

Community-level consumption of antibiotics according to the AWaRe (Access, Watch, Reserve) classification in rural Vietnam.

التفاصيل البيبلوغرافية
العنوان: Community-level consumption of antibiotics according to the AWaRe (Access, Watch, Reserve) classification in rural Vietnam.
المؤلفون: Nguyen NV; Oxford University Clinical Research Unit, Hanoi Unit, Hanoi, Vietnam.; Hanoi University of Pharmacy, Hanoi, Vietnam., Do NTT; Oxford University Clinical Research Unit, Hanoi Unit, Hanoi, Vietnam., Nguyen CTK; Family Medicine Department, Hanoi Medical University, Hanoi, Vietnam.; FilaBavi Health Demographic and Surveillance Site, Hanoi, Vietnam., Tran TK; Family Medicine Department, Hanoi Medical University, Hanoi, Vietnam.; FilaBavi Health Demographic and Surveillance Site, Hanoi, Vietnam., Ho PD; FilaBavi Health Demographic and Surveillance Site, Hanoi, Vietnam.; National Institute of Mathematics, Hanoi, Vietnam., Nguyen HH; FilaBavi Health Demographic and Surveillance Site, Hanoi, Vietnam., Vu HTL; Oxford University Clinical Research Unit, Hanoi Unit, Hanoi, Vietnam., Wertheim HFL; Department of Medical Microbiology and RadboudUMC Center for Infectious Diseases, RadboudUMC, Nijmegen, Netherlands.; University of Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK., van Doorn HR; Oxford University Clinical Research Unit, Hanoi Unit, Hanoi, Vietnam.; University of Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK., Lewycka S; Oxford University Clinical Research Unit, Hanoi Unit, Hanoi, Vietnam.; University of Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK.
المصدر: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2020 Sep; Vol. 2 (3), pp. dlaa048. Date of Electronic Publication: 2020 Sep 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101765283 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2632-1823 (Electronic) Linking ISSN: 26321823 NLM ISO Abbreviation: JAC Antimicrob Resist Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Oxford] : Oxford University Press, [2019]-
مستخلص: Objectives: To review community-level consumption of antibiotics in rural Vietnam, according to the WHO Access, Watch, Reserve (AWaRe) classification of 2019, and identify factors associated with the choice of these antibiotics.
Methods: In this cross-sectional study, data on antibiotic purchases were collected through a customer exit survey of 20 community antibiotic suppliers in Ba Vi District, Hanoi, between September 2017 and July 2018. Antibiotic consumption was estimated through the number of antibiotic encounters, the number of DDDs supplied and the number of treatment days (DOTs) with antibiotics, and analysed according to the AWaRe classification. The factors associated with watch-group antibiotic supply were identified through multivariable logistic regression analysis.
Results: In total, there were 1342 antibiotic encounters, with access-group antibiotics supplied in 792 encounters (59.0%), watch-group antibiotics supplied in 527 encounters (39.3%) and not-recommended antibiotics supplied in 23 encounters (1.7%). No reserve-group antibiotics were supplied. In children, the consumption of watch-group antibiotics dominated in all three measures (54.8% of encounters, 53.0% of DOTs and 53.6% of DDDs). Factors associated with a higher likelihood of watch-group antibiotic supply were: private pharmacy (OR, 4.23; 95% CI, 2.8-6.38; P  <   0.001), non-prescription antibiotic sale (OR, 2.62; 95% CI, 1.78-3.87; P  <   0.001) and children (OR, 2.56; 95% CI, 1.84-3.55; P  <   0.001).
Conclusions: High consumption of watch-group antibiotics was observed, especially for use in children. The frequent supply of watch-group antibiotics at private pharmacies reconfirms the need for implementing pharmacy-targeted interventions in Vietnam.
(© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.)
References: J Antimicrob Chemother. 2008 Aug;62(2):388-96. (PMID: 18434341)
JAMA. 2018 May 15;319(19):1973. (PMID: 29800220)
Antimicrob Resist Infect Control. 2018 Nov 15;7:136. (PMID: 30473786)
Infect Control Hosp Epidemiol. 2015 Jun;36(6):688-94. (PMID: 25817577)
J Antimicrob Chemother. 2018 Dec 1;73(12):3505-3515. (PMID: 30239728)
Mayo Clin Proc. 2011 Feb;86(2):156-67. (PMID: 21282489)
Ther Clin Risk Manag. 2010 Jul 21;6:301-6. (PMID: 20668712)
P T. 2015 Apr;40(4):277-83. (PMID: 25859123)
Microb Drug Resist. 2002 Spring;8(1):27-33. (PMID: 12002646)
Curr Treat Options Infect Dis. 2014;6(2):101-112. (PMID: 25999798)
JAMA. 2017 Dec 19;318(23):2325-2336. (PMID: 29260224)
Can J Infect Dis Med Microbiol. 2005 May;16(3):159-60. (PMID: 18159536)
J Infect. 2019 Jan;78(1):8-18. (PMID: 29981773)
Lancet Infect Dis. 2014 Aug;14(8):742-750. (PMID: 25022435)
BMC Infect Dis. 2010 Mar 31;10:85. (PMID: 20356399)
BMC Public Health. 2013 Dec 10;13:1158. (PMID: 24325208)
Sci Rep. 2018 Aug 15;8(1):12210. (PMID: 30111796)
Am J Infect Control. 2012 Nov;40(9):840-4. (PMID: 22341530)
Int J Antimicrob Agents. 2012 Jun;40 Suppl:S37-43. (PMID: 22749057)
BMJ Evid Based Med. 2019 Jun;24(3):119-120. (PMID: 30361328)
Glob Health Action. 2017;10(1):1327638. (PMID: 28590792)
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470. (PMID: 29581252)
Infect Chemother. 2014 Dec;46(4):226-38. (PMID: 25566402)
S D Med. 2015;Spec No:44-8. (PMID: 25985608)
Infection. 2016 Jun;44(3):395-439. (PMID: 27066980)
BMC Pediatr. 2009 Jun 24;9:41. (PMID: 19552819)
BMC Pharmacol Toxicol. 2014 Feb 20;15:6. (PMID: 24555709)
Pediatrics. 2014 Mar;133(3):375-85. (PMID: 24488744)
Med Clin North Am. 2018 Sep;102(5):913-928. (PMID: 30126580)
Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7. (PMID: 15155207)
Antimicrob Agents Chemother. 2006 Nov;50(11):3646-50. (PMID: 16940064)
Lancet Infect Dis. 2019 Jan;19(1):67-75. (PMID: 30522834)
J Antimicrob Chemother. 2014 Apr;69(4):881-91. (PMID: 24324224)
Br J Gen Pract. 2014 Dec;64(629):604-5. (PMID: 25452508)
Trop Med Int Health. 2009 May;14(5):546-55. (PMID: 19320870)
Lancet Glob Health. 2018 Jul;6(7):e732. (PMID: 29903375)
Wellcome Open Res. 2017 Jul 28;2:58. (PMID: 29707652)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust
تواريخ الأحداث: Date Created: 20200925 Latest Revision: 20220417
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC7497401
DOI: 10.1093/jacamr/dlaa048
PMID: 32974610
قاعدة البيانات: MEDLINE
الوصف
تدمد:2632-1823
DOI:10.1093/jacamr/dlaa048